Literature DB >> 5897736

Electroshock for atrial flutter and atrial fibrillation. Follow-up studies on 50 patients.

J B Jensen, J O Humphries, W B Kouwenhoven, J R Jude.   

Abstract

Entities:  

Mesh：

Year:  1965        PMID： 5897736

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Dabigatran in atrial fibrillation: pharmacology and clinical trials.

Authors:  Michael D Ezekowitz; Rangadham Nagarakanti
Journal:  J Interv Card Electrophysiol       Date:  2011-06-30       Impact factor: 1.900

Review 2.  Role of the new target specific oral anticoagulants in the management of anticoagulation for cardioversion and atrial fibrillation ablation.

Authors:  Marcin Kowalski; Valay Parikh
Journal:  J Thromb Thrombolysis       Date:  2013-08       Impact factor: 2.300

3.  Determinants of recurrent atrial flutter after cardioversion.

Authors:  R G Pozen; J Pastoriza; J J Rozanski; K M Kessler; R J Myerburg
Journal:  Br Heart J       Date:  1983-07

Review 4.  The clinical efficacy of dabigatran etexilate for preventing stroke in atrial fibrillation patients.

Authors:  Christopher R Ellis; Daniel W Kaiser
Journal:  Vasc Health Risk Manag       Date:  2013-07-09

5.  Cardiovascular Events of Electrical Cardioversion Under Optimal Anticoagulation in Atrial Fibrillation: The Multicenter Analysis.

Authors:  Dong Geum Shin; Iksung Cho; Bríain ó Hartaigh; Hee-Sun Mun; Hye-Young Lee; Eui Seock Hwang; Jin-Kyu Park; Jae-Sun Uhm; Hui-Nam Pak; Moon-Hyoung Lee; Boyoung Joung
Journal:  Yonsei Med J       Date:  2015-11       Impact factor: 2.759

6.  Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation.

Authors:  Sufyan Benamer; Debbie Lusty; Tamara Everington
Journal:  Cardiol Ther       Date:  2016-07-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.